Adial Pharmaceuticals Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 24.25 K | $43.41 K | 100.00% | 2.18% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 5.88 K | $10.52 K | 100.00% | 0.53% |
| MANCHESTER CAPITAL MANAGEMENT LLC | 05/11/2026 | 1.92 K | $3.44 K | 100.00% | 0.17% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2026 | 1.36 K | $2.43 K | 100.00% | 0.12% |
| BLACKROCK, INC. | 05/13/2026 | 1.11 K | $1.99 K | 100.00% | 0.10% |
| UBS GROUP AG | 05/05/2026 | 542 | $970 | 100.00% | 0.05% |
| 05/15/2026 | 361 | $646 | 100.00% | 0.03% | |
| MORGAN STANLEY | 05/15/2026 | 50 | $90 | 100.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 04/28/2026 | 47 | $84 | 100.00% | 0.00% |
| CAITONG INTERNATIONAL ASSET MANAGEMENT CO., LTD | 05/11/2026 | 15 | $27 | 100.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 05/11/2026 | 6 | $11 | 100.00% | 0.00% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 05/07/2026 | 4 | $7 | 100.00% | 0.00% |
| HARBOUR INVESTMENTS, INC. | 05/15/2026 | 3 | $5 | 100.00% | 0.00% |
| ABOUND WEALTH MANAGEMENT | 04/10/2026 | 1 | $2 | 100.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 0 | $0 | -100.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 05/11/2026 | 0 | $0 | -100.00% | 0.00% |
| NORTHERN TRUST CORP | 05/14/2026 | 0 | $0 | -100.00% | 0.00% |
| HARBOUR INVESTMENTS, INC. | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| MORGAN STANLEY | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| STONEX GROUP INC. | 05/14/2026 | 0 | $0 | -100.00% | 0.00% |
| PRIVATE MANAGEMENT GROUP INC | 05/08/2026 | 0 | $0 | -100.00% | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| MANCHESTER CAPITAL MANAGEMENT LLC | 05/11/2026 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA SECURITIES, LLC | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| VIRTU FINANCIAL LLC | 05/14/2026 | 0 | $0 | -100.00% | 0.00% |
| JANE STREET GROUP, LLC | 05/12/2026 | 0 | $0 | -100.00% | 0.00% |
| ARMISTICE CAPITAL, LLC | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| UBS GROUP AG | 05/05/2026 | 0 | $0 | -100.00% | 0.00% |
| XTX TOPCO LTD | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 04/28/2026 | 0 | $0 | -100.00% | 0.00% |
| ABOUND WEALTH MANAGEMENT | 04/10/2026 | 0 | $0 | -100.00% | 0.00% |
| BLACKROCK, INC. | 05/13/2026 | 0 | $0 | -100.00% | 0.00% |
Adial Pharmaceuticals Inc institutional Ownership - FAQ's
During the previous two years, 28 institutional investors and hedge funds held shares of Adial Pharmaceuticals Inc. The most heavily invested institutionals were:
GEODE CAPITAL MANAGEMENT, LLC: 24,249
VANGUARD FIDUCIARY TRUST CO: 5,879
Manchester Capital Management LLC: 1,923
Tower Research Capital LLC (TRC): 1,356
BlackRock, Inc.: 1,110
UBS Group AG: 542
3.20% of Adial Pharmaceuticals Inc stock is owned by institutional investors.
Institutional investors have bought a total of 234.87 K shares in the last 24 months. This purchase volume represents approximately $403.98 K in transactions.